EVALUATION OF WEEKLY ESCALATING DOSES OF DICHLOROMETHOTREXATE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORSTESTER WJ; DONEHOWER RC; EDDY JL et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 305-310; BIBL. 20 REF.Article

SEPTICEMIC COMPLICATIONS OF THE CUTANEOUS T-CELL LYMPHOMASPOSNER LE; FOSSIECK BE JR; EDDY JL et al.1981; AM. J. MED.; ISSN 0002-9343; USA; DA. 1981; VOL. 71; NO 8; PP. 210-216; BIBL. 45 REF.Article

COMPARATIVE VALUE OF BONE SCINTIGRAPHY AND RADIOGRAPHY IN MONITORING TUMOR RESPONSE IN SYSTEMICALLY TREATED PROSTATIC CARCINOMA = VALEUR COMPAREE DE LA SCINTIGRAPHIE ET DE LA RADIOGRAPHIE OSSEUSES DANS LA SURVEILLANCE DE LA REPONSE TUMORALE DES CANCERS DE LA PROSTATE TRAITES PAR VOIE GENERALELEVENSON RM; SAUERBRUNN BJL; BATES HR et al.1983; RADIOLOGY; ISSN 0033-8419; USA; DA. 1983; VOL. 146; NO 2; PP. 513-518; ABS. ENG; BIBL. 18 REF.; GRAPH, FIGArticle

5-FLUOROURACIL, METHYL-CCNU, ADRIAMYCIN, AND MITOMYCIN C IN THE TREATMENT OF ADVANCED GASTRIC CANCERBUNN PA JR; NUGENT JL; IHDE DC et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 9; PP. 1287-1293; BIBL. 28 REF.Article

EFFECTIVE TREATMENT OF HORMONALLY-UNRESPONSIVE METASTATIC CARCINOMA OF THE PROSTATE WITH ADRIAMYCIN AND CYCLOPHOSPHAMIDE: METHODS OF DOCUMENTING TUMOR RESPONSE AND PROGRESSIONIHDE DC; BUNN PA; COHEN MH et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 6; PP. 1300-1310; BIBL. 29 REF.Article

COMBINED MODALITY THERAPY WITH ELECTRON-BEAM IRRADIATION AND SYSTEMIC CHEMOTHERAPY FOR CUTANEOUS T-CELL LYMPHOMASBUNN PA JR; FISCHMANN AB; SCHECHTER GP et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 4; PP. 713-717; BIBL. 34 REF.Article